• SENSEX 76,386.20
    -368.85 (--0.48%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,936.05 1,745.00(%)
  • Millworks Technologies
    727.95 693.30(%)
  • Gandhar Oil Ref.
    279.00 245.00(%)
  • Oracle Fin.Serv.
    11,369.75 11,986.90(%)
  • SBI Funds Mgt.
    575.55 582.55(%)
  • Dr Reddy's Labs
    1,080.05 1,149.00(%)
  • Data Pattern
    4,806.35 4,955.00(%)
  • Bluestone Jewel
    792.30 872.60(%)
  • Eternal
    291.30 368.40(%)
  • HDFC Bank
    746.00 726.75(%)
  • Adani Green
    1,420.70 767.00(%)
  • Kalyan Jewellers
    602.00 617.30(%)
  • IndusInd Bank
    1,019.65 710.85(%)
  • H P C L
    376.80 316.20(%)
  • Cupid
    211.00 225.90(%)
  • Uflex
    513.20 609.95(%)
  • Lords Mark Industries
    95.00 669.70(%)
  • MTAR Technologie
    6,150.00 8,714.95(%)
  • MPS
    2,671.50 2,568.35(%)
  • Stylam Industrie
    3,808.35 4,160.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
420.85 -15 (-3.40%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    420.10

  • Today’s High

    441.45

  • Open

    441.00

  • Perv Close

    435.65

  • 52W Low

    248.85

  • 52W High

    479.45

Key Indicators

  • P/E(TTM)

    20.90

  • Mar.Cap (₹Cr.)

    1,238.60

  • Div & Yield %

    0.87

  • Book Value(₹)

    143.79

  • Debt-Equity Ratio

    -3.40

  • AGM Date

    22-Jul-2026

  • EPS

    20.14

  • P/E Ratio

    20.90

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    1,238.60

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    143.80

  • Sales( ₹ in Cr.)

    450.25

  • NP (in Cr.)

    55.23

  • NP Var(%)

    -23.0

  • Div%

    75.0

  • CPS (₹)

    25.90

  • EPS (₹)

    18.80

  • Traded Value (₹ in Lakhs)

    1,238.60

  • 52 Week High

    479.45

  • 52 Week Low

    248.85

  • Price BSE

    421.0

  • Price NSE

    421.00

  • Market Capital( in Cr.)

    1,238.60

  • P/C Ratio

    16.30

  • P/E Ratio

    22.40

  • Price Vs.BV

    18.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 450.25 430.53 307.09 328.91 387.96 372.82
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 450.25 430.53 307.09 328.91 387.96 372.82
Other Income 30.87 11.68 8.15 8.46 7.53 6.62
Stock Adjustments 24.71 7.59 -13.86 -17.29 -7.65 15.88
Total Income 505.83 449.80 301.38 320.08 387.84 395.32
EXPENDITURE :            
Raw Materials 178.07 154.38 91.57 109.21 136.55 139.52
Power and Fuel Cost 29.13 27.23 19.78 18.24 20.35 14.23
Employee Cost 74.14 60.10 53.93 53.81 59.36 57.50
Other Manufacturing Expenses 45.58 48.84 50.29 44.12 43.65 36.06
Selling and Administration Expenses 49.13 39.08 34.46 38.73 38.16 37.25
Miscellaneous Expenses 7.24 7.74 14.87 68.12 5.42 9.41
Employee Benefit Expenses 74.14 60.10 53.93 53.81 59.36 57.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 383.27 337.37 264.90 332.23 303.50 293.96
Operating Profit 122.56 112.43 36.49 -12.14 84.35 101.36
Interest 12.38 14.84 17.40 21.35 18.11 19.10
Gross Profit 110.18 97.59 19.09 -33.49 66.24 82.26
Depreciation 20.94 23.17 23.70 24.49 23.67 19.03
Profit Before Tax 89.24 74.42 -4.61 -57.98 42.57 63.23
Current Tax 14.61 13.12 14.14 -0.97 7.41 11.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 10.35 -6.32 0.00 0.00 4.92 0.00
Reported Net Profit 64.28 67.62 -18.74 -57.00 30.24 51.97
Extraordinary Items 9.05 -4.09 -11.01 -60.09 -0.02 -0.13
Adjusted Net Profit 55.23 71.71 -7.73 3.09 30.26 52.10
Adjustment below Net Profit 0.24 -0.80 0.12 9.52 -0.24 -0.04
P & L Balance brought forward 340.00 276.80 299.03 350.72 327.93 275.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 7.29 3.61 3.61 4.20 7.21 0.00
P & L Balance carried down 397.24 340.00 276.80 299.03 350.72 327.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 75.00 50.00 25.00 25.00 25.00 50.00
Dividend Per Share(Rs) 3.75 2.50 1.25 1.25 1.25 2.50
Earnings Per Share-Unit Curr 22.42 23.18 -6.49 -19.75 10.48 18.01
Earnings Per Share(Adj)-Unit Curr 22.42 23.18 -6.49 -19.75 10.48 18.01
Book Value 147.47 130.26 108.83 116.45 137.26 128.42
Book Value(Adj)-Unit Curr 147.47 130.26 108.83 116.45 137.26 128.42

Shareholding Pattern

  • Promoter Group

    64.09%

  • Public Share Holding

    33.36%

  • Custodian

    2.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 2,240,376 2,240,376.00 2,240,376 2,240,376
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,240,376 7.61 2,240,376 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,620,633 56.47 16,620,633 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,620,633 56.47 16,620,633 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 37,298 0.13 37,298 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 387 0.00 387 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,329 0.04 11,329 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 49,134 0.17 49,134 7
2] Non Institution
Bodies Corporate 362,288 1.23 361,688 127
Clearing Members 100,508 0.34 100,508 10
Directors of their Relatives 144,410 0.49 144,410 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 244,445 0.83 244,445 377
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 277,289 0.94 277,289 425
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,669,359 9.07 2,669,359 20
Individuals holding nominal share capital up to Rs. 1 lakh 5,667,627 19.26 5,482,018 13,143
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 34,480 0.12 34,480 2
Others 195,844 0.67 195,844 3
Sub Total 9,770,448 33.20 9,584,239 14,119
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 750,396 2.55 750,396 1
Total Shares held by Custodians and against which Depository Receipts have been issued 750,396 2.55 750,396 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,244,778 14,131

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

    Srikant N Sharma

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77